Pharmaceutical Commerce

FTC–Express Scripts Settlement Targets PBM Rebates, Transparency, and Patient Drug Costs

1. FTC Secures Landmark Settlement with Express Scripts to Lower Drug Costs for American Patients. United States Federal ...
The Silicon Review

Express Scripts, FTC Settle Landmark Insulin Lawsuit

The FTC's landmark settlement forces Express Scripts PBM to overhaul practices, banning the preference of expensive insulin ...
Seeking Alpha

Express Scripts Adds Three Biosimilars to Largest Formulary to Promote Competition and Advance Affordability, Choices for Patients

Express Scripts will include Cyltezo and both Sandoz products (Hyrimoz and unbranded adalimumab-adaz) – inflammatory disease biosimilars with competitive net costs – as preferred products on the ...
Becker's Hospital Review

Express Scripts to launch formulary for lower list price drugs

Express Scripts Holding, a pharmacy benefit manager that negotiates drug prices for many health plans, will launch a formulary with lower list price drugs in an effort to reduce reliance on rebates ...
Fierce Healthcare

Express Scripts joins Optum in adding more Humira biosimilars to its formulary

On the heels of a similar announcement from Optum Rx, pharmacy benefit management giant Express Scripts said Monday that it will add three biosimilars to its formulary to compete with Humira. The PBM ...

Cigna PBM Express Scripts settles FTC insulin pricing case

Express Scripts, a pharmacy benefit manager and subsidiary of Cigna (CI), has reached a settlement with the FTC over ...
Nasdaq

INPEFA® (Sotagliflozin) Receives Preferred Formulary Status With Express Scripts For Medicare Patients

Express Scripts has determined that it will list INPEFA as a preferred product on Medicare national formularies on November 1, 2023 THE WOODLANDS, Texas, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Lexicon ...